Profilo
Darcy Mootz is currently Director at Alpha-9 Oncology, Inc. and President at Architect Therapeutics, Inc. Former roles include Senior Director-Corporate Development at Achaogen, Inc., Independent Director at Elevation Oncology, Inc. from 2024 to 2025, Head at Amunix Pharmaceuticals, Inc. from 2022 to 2023, and Chief Business Officer at Oric Pharmaceuticals, Inc. Education includes undergraduate studies at Duke University and a doctorate from Harvard University.
Posizioni attive di Darcy Mootz
| Società | Posizione | Inizio |
|---|---|---|
Alpha-9 Oncology, Inc.
Alpha-9 Oncology, Inc. BiotechnologyHealth Technology Engages in research clinical stage radiopharmaceutical and drug design for cancer treatment | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Darcy Mootz
| Società | Posizione | Fine |
|---|---|---|
| ELEN ONCO | Direttore/Membro del Consiglio | 23/07/2025 |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops transformative T cell engagers (TCEs) and cytokine therapies for patients with cancer | Corporate Officer/Principal | 01/04/2023 |
| ORIC PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| ACHAOGEN | Corporate Officer/Principal | - |
Formazione di Darcy Mootz
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Achaogen, Inc.
Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections | Health Technology |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oric Pharmaceuticals, Inc.
Oric Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops pharmaceutical products | Health Technology |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops transformative T cell engagers (TCEs) and cytokine therapies for patients with cancer | Health Technology |
Elevation Oncology, Inc.
Elevation Oncology, Inc. Pharmaceuticals: MajorHealth Technology Develops elevating precision medicines for cancer treatment | Health Technology |
Alpha-9 Oncology, Inc.
Alpha-9 Oncology, Inc. BiotechnologyHealth Technology Engages in research clinical stage radiopharmaceutical and drug design for cancer treatment | Health Technology |
















